The price of Zepbound vials is less than the list price of the ... rather than a vial full of liquid that patients must draw ...

Leerink Partners analyst Thomas Smith maintained a Buy rating on Argenx Se (ARGX – Research Report) yesterday and set a price target of ...

The woman was accused of selling counterfeit versions of popular weight loss drugs, including Ozempic and Wegovy. Experts say ...

Eli Lilly is partnering with the Flatiron-based telehealth company Ro to sell a cheaper version of its popular weight-loss ...

Equities research analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP – Get Free Report) in a report released on Friday. The firm set a “hold” rating on the ...

Medications are a lifeline for millions, but for many, the high cost of prescriptions can lead to serious health consequences ...

Instagram post (direct link, archive link) shows a syringe extracting fluid from a vial and claims a cure has been developed ...

Cheap stocks are worth considering now due to expected interest rate cuts, potential market rebounds, and substantial upside ...

Alien: Rogue Incursion is the first full-blown VR-native in the storied franchise, serving up hordes of Xenomorphs in an ...

AI services exploded into the mainstream in 2023, setting the stage for what appears to be the next great tech leap of this ...

Before you book your next stay, make sure you are aware of the dirtiest hotel chains in America and read the reviews!

Bernstein analyst Delphine Le Louet maintained a Buy rating on Gerresheimer (0NTI – Research Report) today and set a price target of €100.30.